Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome

Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Clément François, John M. Stern, Augustina Ogbonnaya, Tasneem Lokhandwala, Pamela Landsman-Blumberg, Amy Duhig, Vivienne Shen, Robin Tan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2017-01-01
Edice:	Journal of Market Access & Health Policy
Témata:	Lennox-Gastaut syndrome seizure antiepileptic drugs clobazam seizure-related costs
On-line přístup:	http://dx.doi.org/10.1080/20016689.2017.1318691
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!